Mid Cap Healthcare
Stocks Ranked by
Market Capitalization
| Name | Market cap | Price |
Price change % |
|
|---|---|---|---|---|
|
MESO
151
Mesoblast
MESO
$2.2B
| $2.2B | $16.94 | 1.56% |
|
152
HUTCHMED
HCM
$2.18B
| $2.18B | $12.55 | 0% |
|
153
AtriCure
ATRC
$2.14B
| $2.14B | $42.10 | 1.1% |
|
154
Pediatrix Medical
MD
$2.13B
| $2.13B | $26.23 | 0.58% |
|
155
NeoGenomics
NEO
$2.13B
| $2.13B | $16.56 | 0.42% |
|
156
Progyny
PGNY
$2.11B
| $2.11B | $27.53 | 1.15% |
|
157
Biohaven
BHVN
$2.11B
| $2.11B | $13.99 | 3.78% |
|
158
Ocular Therapeutix
OCUL
$2.07B
| $2.07B | $9.43 | 2.06% |
|
159
Aurinia Pharmaceuticals
AUPH
$2.05B
| $2.05B | $15.39 | 0.39% |
|
160
GH Research
GHRS
$2.05B
| $2.05B | $29.81 | 0.95% |
|
161
Stoke Therapeutics
STOK
$2.04B
| $2.04B | $31.59 | 1.99% |
|
162
Aveanna Healthcare
AVAH
$2.04B
| $2.04B | $9.36 | 1.06% |
|
163
NovoCure
NVCR
$2.02B
| $2.02B | $17.39 | 0.46% |
|
|
NBTX
164
Nanobiotix
NBTX
$2.02B
| $2.02B | $39.77 | 9.92% |
|
165
Surgery Partners
SGRY
$2.02B
| $2.02B | $15.41 | 3.39% |
|
Mid Cap Healthcare Stocks at a Glance
Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.
There are 165 mid cap Healthcare stocks — companies in the Healthcare sector with a market cap between $2B and $10B — worth a combined $740B.
The largest by market cap are Insulet (PODD) at $9.92B, Krystal Biotech (KRYS) at $9.86B and Tempus AI (TEM) at $9.78B.
Among institutional investors, ImmunityBio (IBRX) drew the most net new fund positions in Q1 2026: 145 funds opened new positions, taking total fund holders up 109 (39%) quarter-over-quarter.
- Combined market cap: $740B across 165 stocks.
- Mid Cap: market cap between $2B and $10B.
- Largest constituent: Insulet (PODD), $9.92B market cap.
- Most net new fund positions in Q1 2026: ImmunityBio (IBRX), +109 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.